Shaw J H, Wolfe R R
University Department of Surgery, Auckland Hospital, New Zealand.
Ann Surg. 1988 Mar;207(3):274-82. doi: 10.1097/00000658-198803000-00009.
We have assessed the effect of a variety of forms of metabolic intervention on both energy and protein metabolism in 44 severely ill surgical patients. The patients were studied either in the basal state or while receiving total parenteral nutrition (TPN), and the metabolic effects were assessed using the primed-constant infusion of a combination of stable isotopes and radioisotopes. Somatostatin infusion, either in the basal state or in the TPN, did not change glucose kinetics, but there was a significant decrease in the rate of net protein catabolism (NPC). In the basal studies the rate of NPC decreased from 3.4 +/- 0.7 g/kg/d to 2.9 +/- 0.7 g/kg/d (p less than 0.002), while in the TPN patients the corresponding values were 1.48 +/- 0.61 g/kg/d and 1.10 +/- 0.50 g/kg/d, respectively (p less than 0.005). Histamine type 2 blockade with ranitidine did not significantly alter glucose kinetics, but in both the TPN patients and in the basal state ranitidine was associated with a significant decrease in the rate of NPC. In the basal state rate of NPC was 2.44 +/- 0.53 g/kg/d and during ranitidine infusion the value was 2.08 +/- 0.42 g/kg/d (p less than 0.04). Naloxone infusion did not alter glucose kinetics, but there was a significant decrease in the rate of NPC from a basal value of 2.6 +/- 0.6 g/kg/d to 2.3 +/- 0.5 g/kg/d (p less than 0.04). The infusion of the prostaglandin antagonists diclofenac or dipyridamole resulted in increases in the plasma insulin level, and as a result glucose turnover decreased in both groups. In the diclofenac group the rate of glucose turnover decreased from 14.4 +/- 1.7 mumol/kg/min to 12.6 +/- 1.3 mumol/kg/min (p less than 0.02). Neither prostaglandin antagonist resulted in any significant change in the rate of NPC. Beta-adrenergic stimulation with salbutamol resulted in a significant increase in glucose turnover from 12.1 +/- 1.1 mumol/kg/min to 13.4 +/- 0.9 mumol/kg/min (p less than 0.02), and the rates of appearance (Ra) of both alanine and free fatty acids (FFAs) also increased. Alanine Ra increased from 11.7 +/- 2.5 mumol/kg/min to 12.8 +/- 3.0 mumol/kg/min, and the corresponding values for FFA turnover were 7.6 +/- 1.1 mumol/kg/min and 10.3 +/- 2.1 mumol/kg/min (p less than 0.03), respectively. Salbutamol infusion did not result in any significant change in the rate of NPC.(ABSTRACT TRUNCATED AT 400 WORDS)
我们评估了多种形式的代谢干预对44例重症外科患者能量和蛋白质代谢的影响。这些患者在基础状态下或接受全胃肠外营养(TPN)时接受研究,代谢效应通过稳定同位素和放射性同位素组合的首剂量恒速输注来评估。在基础状态或TPN状态下输注生长抑素,并未改变葡萄糖动力学,但净蛋白质分解代谢(NPC)率显著降低。在基础研究中,NPC率从3.4±0.7g/kg/d降至2.9±0.7g/kg/d(p<0.002),而在接受TPN的患者中,相应值分别为1.48±0.61g/kg/d和1.10±0.50g/kg/d(p<0.005)。用雷尼替丁进行组胺2型阻断并未显著改变葡萄糖动力学,但在接受TPN的患者和基础状态下,雷尼替丁均与NPC率显著降低相关。在基础状态下,NPC率为2.44±0.53g/kg/d,在输注雷尼替丁期间,该值为2.08±0.42g/kg/d(p<0.04)。输注纳洛酮未改变葡萄糖动力学,但NPC率从基础值2.6±0.6g/kg/d显著降至2.3±0.5g/kg/d(p<0.04)。输注前列腺素拮抗剂双氯芬酸或双嘧达莫导致血浆胰岛素水平升高,结果两组的葡萄糖周转率均降低。在双氯芬酸组,葡萄糖周转率从14.4±1.7μmol/kg/min降至12.6±1.3μmol/kg/min(p<0.02)。两种前列腺素拮抗剂均未使NPC率发生任何显著变化。用沙丁胺醇进行β-肾上腺素能刺激导致葡萄糖周转率从12.1±1.1μmol/kg/min显著增加至13.4±0.9μmol/kg/min(p<0.02),丙氨酸和游离脂肪酸(FFA)的出现率(Ra)也增加。丙氨酸Ra从11.7±2.5μmol/kg/min增加至12.8±3.0μmol/kg/min,FFA周转率的相应值分别为7.6±1.1μmol/kg/min和10.3±2.1μmol/kg/min(p<0.03)。输注沙丁胺醇未使NPC率发生任何显著变化。(摘要截短至400字)